ChargePoint Technology expands into Europe with new Munich site

The company has seen demand skyrocket in the region.
ChargePoint Technology, a pharmaceutical containment and aseptic processing specialist, has opened a new facility outside Munich, Germany in response to increasing demand.
The new 75m sq site will support customers in the region with onsite consultations, virtual demonstrations and technical support. The company, whose headquarters are in the UK, says the move aligns with its goal of expanding into the DACH region, which comprises of Germany, Austria and Switzerland.
ChargePoint Technology creates containment and aseptic transfer valves and single-use solutions that are essential for the safe transfer of powders during pharmaceutical and biopharmaceutical manufacturing. The Munich facility will be headed up by Patrick Werner, regional manager for the DACH region.
Speaking about the expansion, ChargePoint Technology CEO Chris Eccles said: ‘In the last four years we have tripled our order intake in the region and I’m sure this growth will continue with Patrick and the team now permanently based in the area. This new investment and expansion of the team in the DACH region demonstrates ChargePoint's commitment to the region and our valued customers. We will continue to add the resources necessary to support our customer base in the territory as we grow.’
The company reported significant growth in its business over the last year, which promted an expansion of its US offices. In January, ChargePoint also acquired US-based Terracon Corporation, a manufacturer of single-use products and accessories for mixing, transferring, and storing liquids and fluids in the biopharma and life science markets.
Related News
-
News CordenPharma Increases xRNA-based Capabilities at its Caponago Injectable Facility
CordenPharma, a full-service CDMO of APIs, Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy. -
News Western countries consider stockpiles, place orders for vaccine against monkeypox
The US, Canada, UK, France, Germany, and Spain are among several countries to purchase vaccine doses. -
News Pharmapack Awards 2022: Winners Revealed
The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. -
News First SPAC focused on biopharma products launches in Europe
A special purpose acquisition company (SPAC) focused on absorbing companies that make medicines for the biotech and pharmaceutical industry has launched in Europe. -
News Private equity firm to acquire CDMO CordenPharma from ICIG
Astorg has agreed to acquire the CDMO from privately-owned industrial group ICIG -
News How is tech shaping pharma packaging and drug delivery?
For a full rundown on tech trends driving the sector, catch these five sessions at Pharmapack 2022 -
News Onyx Scientific expands small molecule CMC services with new UK facility
The contract development and manufacturing organisation (CDMO) has completed the first phase of its multi-million-pound development. -
News Supply chain disruptions continue, but is the end in sight?
Supply chain disruptions have become the new normal. Recurring pandemic waves, inflation, trade jitters and a war in Europe have done little to quell C-suite anxieties.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance